These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 14672806)

  • 1. Effect of repeated administration of TRK-820, a kappa-opioid receptor agonist, on tolerance to its antinociceptive and sedative actions.
    Suzuki T; Izumimoto N; Takezawa Y; Fujimura M; Togashi Y; Nagase H; Tanaka T; Endoh T
    Brain Res; 2004 Jan; 995(2):167-75. PubMed ID: 14672806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The novel kappa-opioid receptor agonist TRK-820 has no affect on the development of antinociceptive tolerance to morphine in mice.
    Tsuji M; Yamazaki M; Takeda H; Matsumiya T; Nagase H; Tseng LF; Narita M; Suzuki T
    Eur J Pharmacol; 2000 Apr; 394(1):91-5. PubMed ID: 10771039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological characterization of ATPM [(-)-3-aminothiazolo[5,4-b]-N-cyclopropylmethylmorphinan hydrochloride], a novel mixed kappa-agonist and mu-agonist/-antagonist that attenuates morphine antinociceptive tolerance and heroin self-administration behavior.
    Wang YJ; Tao YM; Li FY; Wang YH; Xu XJ; Chen J; Cao YL; Chi ZQ; Neumeyer JL; Zhang A; Liu JG
    J Pharmacol Exp Ther; 2009 Apr; 329(1):306-13. PubMed ID: 19136637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRK-820, a selective kappa-opioid agonist, produces potent antinociception in cynomolgus monkeys.
    Endoh T; Tajima A; Izumimoto N; Suzuki T; Saitoh A; Suzuki T; Narita M; Kamei J; Tseng LF; Mizoguchi H; Nagase H
    Jpn J Pharmacol; 2001 Mar; 85(3):282-90. PubMed ID: 11325021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent antinociceptive effects of TRK-820, a novel kappa-opioid receptor agonist.
    Endoh T; Matsuura H; Tajima A; Izumimoto N; Tajima C; Suzuki T; Saitoh A; Suzuki T; Narita M; Tseng L; Nagase H
    Life Sci; 1999; 65(16):1685-94. PubMed ID: 10573186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of pharmacological activities of three distinct kappa ligands (Salvinorin A, TRK-820 and 3FLB) on kappa opioid receptors in vitro and their antipruritic and antinociceptive activities in vivo.
    Wang Y; Tang K; Inan S; Siebert D; Holzgrabe U; Lee DY; Huang P; Li JG; Cowan A; Liu-Chen LY
    J Pharmacol Exp Ther; 2005 Jan; 312(1):220-30. PubMed ID: 15383632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential properties between TRK-820 and U-50,488H on the discriminative stimulus effects in rats.
    Mori T; Nomura M; Yoshizawa K; Nagase H; Narita M; Suzuki T
    Life Sci; 2004 Oct; 75(20):2473-82. PubMed ID: 15350822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the antinociceptive effects of TRK-820 in the rat.
    Endoh T; Tajima A; Suzuki T; Kamei J; Narita M; Tseng L; Nagase H
    Eur J Pharmacol; 2000 Jan; 387(2):133-40. PubMed ID: 10650153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of mu-opioid receptor-mediated G-protein activation and antinociception by TRK-820 in mice.
    Mizoguchi H; Hung KC; Leitermann R; Narita M; Nagase H; Suzuki T; Tseng LF
    Eur J Pharmacol; 2003 Feb; 461(1):35-9. PubMed ID: 12568913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel kappa-opioid receptor agonist, TRK-820, blocks the development of physical dependence on morphine in mice.
    Tsuji M; Takeda H; Matsumiya T; Nagase H; Yamazaki M; Narita M; Suzuki T
    Life Sci; 2000; 66(25):PL353-8. PubMed ID: 10894094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of acute herpetic pain-related responses by the kappa-opioid receptor agonist (-)-17-cyclopropylmethyl-3,14beta-dihydroxy-4,5alpha-epoxy-beta-[n-methyl-3-trans-3-(3-furyl) acrylamido] morphinan hydrochloride (TRK-820) in mice.
    Takasaki I; Suzuki T; Sasaki A; Nakao K; Hirakata M; Okano K; Tanaka T; Nagase H; Shiraki K; Nojima H; Kuraishi Y
    J Pharmacol Exp Ther; 2004 Apr; 309(1):36-41. PubMed ID: 14711930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional interaction among opioid receptor types: up-regulation of mu- and delta-opioid receptor functions after repeated stimulation of kappa-opioid receptors.
    Khotib J; Narita M; Suzuki M; Yajima Y; Suzuki T
    Neuropharmacology; 2004 Mar; 46(4):531-40. PubMed ID: 14975677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of cocaine with morphine, U-50,488H and [D-Pen2, D-Pen5]enkaphalin.
    Bhargava HN; Cao YJ
    Peptides; 1998; 19(3):563-8. PubMed ID: 9533646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-type Ca2+ channel modulation by dihydropyridines potentiates kappa-opioid receptor agonist induced acute analgesia and inhibits development of tolerance in rats.
    Gullapalli S; Ramarao P
    Neuropharmacology; 2002 Mar; 42(4):467-75. PubMed ID: 11955518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug design and synthesis of a novel kappa opioid receptor agonist with an oxabicyclo[2.2.2]octane skeleton and its pharmacology.
    Nagase H; Watanabe A; Nemoto T; Yamaotsu N; Hayashida K; Nakajima M; Hasebe K; Nakao K; Mochizuki H; Hirono S; Fujii H
    Bioorg Med Chem Lett; 2010 Jan; 20(1):121-4. PubMed ID: 19962305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of spinal kappa opioid receptors in the blockade of the development of antinociceptive tolerance to morphine.
    Takahashi M; Senda T; Kaneto H
    Eur J Pharmacol; 1991 Aug; 200(2-3):293-7. PubMed ID: 1664330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonergic involvement in the antinociceptive action of and the development of tolerance to the kappa-opioid receptor agonist, U-50, 488H.
    Ho BY; Takemori AE
    J Pharmacol Exp Ther; 1989 Aug; 250(2):508-14. PubMed ID: 2547935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of observable behaviors induced by typical and atypical kappa-opioid receptor agonists in male rhesus monkeys.
    Huskinson SL; Platt DM; Brasfield M; Follett ME; Prisinzano TE; Blough BE; Freeman KB
    Psychopharmacology (Berl); 2020 Jul; 237(7):2075-2087. PubMed ID: 32372348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a newly synthesized kappa-opioid receptor agonist, TRK-820, on the discriminative stimulus and rewarding effects of cocaine in rats.
    Mori T; Nomura M; Nagase H; Narita M; Suzuki T
    Psychopharmacology (Berl); 2002 Apr; 161(1):17-22. PubMed ID: 11967626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effects of TRK-820 on systemic skin scratching induced by morphine in rhesus monkeys.
    Wakasa Y; Fujiwara A; Umeuchi H; Endoh T; Okano K; Tanaka T; Nagase H
    Life Sci; 2004 Oct; 75(24):2947-57. PubMed ID: 15454345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.